Tauber, E., Kollaritsch, H., von Sonnenburg, F., Lademann, M., Jilma, B., Firbas, C., Jelinek, T., Beckett, C., Knobloch, J., McBride, W.J.H., Schuller, E., Kaltenbock, A., Sun, W., and Lyons, A. (2008) Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. Journal of Infectious Diseases, 198 (4). pp. 1-7.